Vol 54, No 3 (2020)
Short communication
Published online: 2020-04-14
Submitted: 2020-03-12
Accepted: 2020-03-23
Get Citation

Radiation therapy in patients with implanted deep brain stimulation

Michał J. Schinwelski, Jarosław Dulski, Wojciech Łuczak, Witold Libionka, Tomasz Mandat, Jarosław Sławek
DOI: 10.5603/PJNNS.a2020.0033
·
Pubmed: 32285432
·
Neurol Neurochir Pol 2020;54(3):280-283.

paid access

Vol 54, No 3 (2020)
Short communication
Published online: 2020-04-14
Submitted: 2020-03-12
Accepted: 2020-03-23

Abstract

Background. As deep brain stimulation (DBS) and radiation therapy (RT) have become established treatments for movement disorders and malignancies respectively, patients being treated with both simultaneously are becoming more frequent.

Objectives. Literature regarding the safety of RT in patients with implanted DBS is scarce, and there are no clear guidelines on how to manage them.

Methods. We present a follow-up of two Parkinson’s Disease (PD) patients with DBS undergoing RT in the context of previous literature.

Results. No adverse events nor malfunctioning of the DBS system were observed. This was in line with previous reports.

Conclusions.
Since there are no clear safety guidelines for RT in DBS patients, it is important to document experience in this field. A combined approach involving multidisciplinary discussions between neurosurgeons, radiotherapists, clinical oncologists and neurologists is recommended.

Abstract

Background. As deep brain stimulation (DBS) and radiation therapy (RT) have become established treatments for movement disorders and malignancies respectively, patients being treated with both simultaneously are becoming more frequent.

Objectives. Literature regarding the safety of RT in patients with implanted DBS is scarce, and there are no clear guidelines on how to manage them.

Methods. We present a follow-up of two Parkinson’s Disease (PD) patients with DBS undergoing RT in the context of previous literature.

Results. No adverse events nor malfunctioning of the DBS system were observed. This was in line with previous reports.

Conclusions.
Since there are no clear safety guidelines for RT in DBS patients, it is important to document experience in this field. A combined approach involving multidisciplinary discussions between neurosurgeons, radiotherapists, clinical oncologists and neurologists is recommended.

Get Citation

Keywords

deep brain stimulation, radiation therapy, Parkinson’s Disease, safety guidelines

About this article
Title

Radiation therapy in patients with implanted deep brain stimulation

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 54, No 3 (2020)

Pages

280-283

Published online

2020-04-14

DOI

10.5603/PJNNS.a2020.0033

Pubmed

32285432

Bibliographic record

Neurol Neurochir Pol 2020;54(3):280-283.

Keywords

deep brain stimulation
radiation therapy
Parkinson’s Disease
safety guidelines

Authors

Michał J. Schinwelski
Jarosław Dulski
Wojciech Łuczak
Witold Libionka
Tomasz Mandat
Jarosław Sławek

References (15)
  1. Ponce FA, Lozano AM. Deep brain stimulation state of the art and novel stimulation targets. Prog Brain Res. 2010; 184: 311–324.
  2. Delaney G, Jacob S, Featherstone C, et al. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005; 104(6): 1129–1137.
  3. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87–108.
  4. Szlufik S, Przybyszewski A, Dutkiewicz J, et al. Evaluating reflexive saccades and UDPRS as markers of Deep Brain Stimulation and Best Medical Treatment improvements in Parkinson's disease patients: a prospective controlled study. Neurol Neurochir Pol. 2019; 53(5): 341–347.
  5. Smilowska K, Bloem BR, Esselink RAJ, et al. Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation. Parkinsonism Relat Disord. 2020; 71: 15–16.
  6. Nutt JG, Anderson VC, Peacock JH, et al. DBS and diathermy interaction induces severe CNS damage. Neurology. 2001; 56(10): 1384–1386.
  7. Henderson JM, Tkach J, Phillips M, et al. Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery. 2005; 57(5): E1063; discussion E1063.
  8. Medtronic DBS Systems INDICATIONS, SAFETY, AND WARNINGS. https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/neurological/deep-brain-stimulation/indications-safety-warnings/brief-statement-movement-disorders.html (Nov 2017).
  9. Mazdai G, Stewart DP, Hounsell AR. Radical radiation therapy in a patient with head and neck cancer and severe Parkinson's disease. Clin Oncol (R Coll Radiol). 2006; 18(1): 82–84.
  10. Borkenhagen JF, Morris ZS, Hoberg JR, et al. Delivery of definitive dose external beam radiation in close proximity to an implanted deep brain stimulator. Pract Radiat Oncol. 2014; 4(5): 294–297.
  11. Munshi A, Agarwal JP, Pandey KC. Cancer patients with cardiac pacemakers needing radiation treatment: a systematic review. J Cancer Res Ther. 2013; 9(2): 193–198.
  12. Guy JB, Levy A, Malkoun N, et al. Preventing radiotherapy-induced side effects on deep brain stimulators: the need for a multidisciplinary management. Br J Neurosurg. 2014; 28(1): 107–109.
  13. Kotecha R, Berriochoa CA, Murphy ES, et al. Report of whole-brain radiation therapy in a patient with an implanted deep brain stimulator: important neurosurgical considerations and radiotherapy practice principles. J Neurosurg. 2016; 124(4): 966–970.
  14. Zaremba T, Jakobsen AR, Søgaard M, et al. Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review. Europace. 2016; 18(4): 479–491.
  15. Son BC, Kim JS, Park WC, et al. Management of Pulse Generators in a Breast Cancer Patient with in Situ Subthalamic Nucleus Deep Brain Stimulation. J Neurol Surg A Cent Eur Neurosurg. 2019; 80(3): 223–227.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl